Stocktoria
NEPHROS INC NEPH
NEPHROS INC financials (annual)
Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $18.8M | $14.2M | $14.2M | $10.0M | $10.2M | $8.6M | $10.3M | $5.7M | $3.8M | $2.3M |
| Gross profit | $11.6M | $8.7M | $8.4M | $4.7M | $5.6M | $4.9M | $6.1M | $3.2M | $2.3M | $1.3M |
| R&D expense | $1.3M | $906,000 | $873,000 | $1.3M | $1.5M | $2.8M | $3.1M | $1.5M | — | — |
| SG&A expense | $9.0M | $7.7M | $8.9M | $7.6M | $7.2M | $6.5M | $6.1M | $4.5M | $3.3M | $2.9M |
| Operating income | $1.1M | $6,000 | -$1.6M | -$4.3M | -$3.3M | -$4.3M | -$3.2M | -$3.0M | -$2.2M | -$2.9M |
| Interest expense | — | — | $2,000 | $20,000 | $41,000 | $110,000 | $195,000 | $172,000 | $302,000 | $172,000 |
| Income tax | $12,000 | $15,000 | $0 | $0 | $0 | — | -$225,000 | -$93,000 | -$1.8M | — |
| Net income | $1.2M | $74,000 | -$1.6M | — | -$3.9M | -$4.5M | -$3.2M | -$3.4M | -$809,000 | -$3.0M |
| EPS (diluted) | $0.11 | $0.01 | $-0.15 | $-0.73 | — | — | — | — | — | — |
| Operating cash flow | $1.6M | -$500,000 | $827,000 | -$3.2M | -$1.4M | -$6.9M | -$2.3M | -$3.7M | -$77,000 | -$2.1M |
| Free cash flow | — | -$555,000 | $752,000 | -$3.4M | -$1.5M | -$7.1M | -$2.3M | — | — | -$2.2M |
| Cash & equivalents | $5.4M | $3.8M | $4.3M | $3.6M | $7.0M | $8.2M | $4.2M | — | — | — |
| Inventory | $3.2M | $2.6M | $2.5M | $3.2M | $4.5M | $5.3M | $2.6M | $1.9M | $674,000 | $479,000 |
| Total assets | $13.6M | $11.2M | $11.9M | $11.0M | $17.6M | $18.5M | $11.6M | $10.6M | $5.0M | $2.7M |
| Total liabilities | $3.4M | $2.6M | $3.5M | $2.1M | $2.9M | $2.9M | $3.9M | $3.8M | $3.0M | $2.0M |
| Shareholders' equity | $10.2M | $8.6M | $8.4M | $8.9M | $14.7M | $15.6M | $7.7M | $6.8M | $1.9M | $667,000 |
Growth · year-over-year · Revenue CAGR 26.2%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | +32.7% | -0.5% | +42.7% | -2.4% | +19.3% | -17.2% | +81.7% | +49.3% | +64.2% | +19.3% |
| Net income growth | +1513.5% | — | — | — | — | — | — | — | — | — |
| EPS growth | +1000.0% | — | — | — | — | — | — | — | — | — |
| Free cash flow growth | — | -173.8% | — | — | — | — | — | — | — | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.